supervisors approve GSK Marietta expansion that would ... plan that provided for the demolition of a building and constructing a new, approximately 122,000-square-foot building, parking and ...

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

5. What happened: Supervisors approved GSK Marietta’s preliminary/final land development plan which would demolish a portion of a building and construct a new, approximately 122,000-square-foot ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

GSK has agreed to pay up to $2.2 billion to resolve ... Zantac has since returned to the market with a new formulation that does not include ranitidine. Companies facing federal litigation gained ...

Building this trust among employees involves ... is aiming to “do the right thing” for wider society. With the new goals, GSK aims to have a net zero impact on climate and a net positive ...

Harvey Jones is thrilled to see the GSK share price rebound this morning after a great big legal cloud has lifted. Now he ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

Success comes from continuously testing strategies, using A/B testing and real-time feedback to refine what works.

The shots are important for both Pfizer and GSK as they look to build new franchises before top-selling drugs face generic competition later this decade. Pfizer is also contending with activist ...

A new $72 million award aims to double the U.S ... As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza.

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...